Dr. Gugelmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Basel, Switzerland
San Francisco, CA 94112
Summary
- Dr. Hallam Gugelmann is a medical toxicologist and senior medical director in drug development living in Basel Switzerland.
Education & Training
- University of California (San Francisco)Fellowship, Medical Toxicology (Emergency Medicine), 2013 - 2015
- University of Pennsylvania Health SystemResidency, Emergency Medicine, 2009 - 2013
- University of North Carolina at Chapel Hill School of MedicineClass of 2009
- University of North CarolinaMPH, 2007 - 2008
- Johns Hopkins UniversityBA, English, 1998 - 2001
Certifications & Licensure
- CA State Medical License 2013 - 2026
- PA State Medical License 2009 - 2014
- American Board of Emergency Medicine Emergency Medicine
- American Board of Emergency Medicine Medical Toxicology
Awards, Honors, & Recognition
- Fellow of the American College of Emergency Physicians 2018
- CPC Semi-Finalist SAEM, 2011
- Frank Porter Graham Graduate and Professional Student Honor Society 2009
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsEffects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammation.Hubert Chen, Rebecca Kunder, Yixuan Zou, Tracy Staton, Rui Zhu
Pulmonary Pharmacology & Therapeutics. 2022-08-01 - 5 citationsButanediol Conversion to Gamma-Hydroxybutyrate Markedly Reduced by the Alcohol Dehydrogenase Blocker Fomepizole.Evangelia Liakoni, Hallam Gugelmann, Delia A. Dempsey, Timothy J. Wiegand, Christopher Havel
Clinical Pharmacology and Therapeutics. 2019-05-01 - 18 citationsSnakebites and climate change in California, 1997-2017Caleb Phillips, Grant S. Lipman, Hallam Gugelmann, Katie Doering, Derrick Lung
Clinical Toxicology. 2019-03-01
Journal Articles
- Butanediol Conversion to Gamma‐Hydroxybutyrate Markedly Reduced by the Alcohol Dehydrogenase Blocker FomepizoleNeal L Benowitz, Hallam Gugelmann, Delia A Dempsey, Clinical Pharmacology & Therapeutics
- Racial disparities across provider specialties in opioid prescriptions dispensed to medicaid beneficiaries with chronic noncancer painRingwalt C, Roberts AW, Gugelmann H, Skinner AC, Pain Med., 1/1/2015
- Young Woman With SeizuresLi K, Gugelmann H, Tabas JA., Ann Emerg Med., 1/1/2015
- Join now to see all
Books/Book Chapters
Lectures
- Naloxone: The Fundamentals for Pharmacists involved in Dispensing to Caregivers and Patients at risk for Opiate and Opioid Overdose and Toxicity.1/1/2015
- Ease of Identifying and Purchasing Popular �Research Chemicals� via the Internet1/1/2015
- Change in Provider Perspectives About Opioid Analgesics Following a Multidisciplinary Educational Intervention to Enhance Safe Opioid Use1/1/2015
- Join now to see all
Other
- �Crazy Monkey� synthetic cannabinoid ingestionCBS Online interview and article
http://tinyurl.com/lub78xp
1/29/2014 - Prescription opioid epidemicKQED Radio broadcast
1/29/2014
Press Mentions
- Price of Drug That Saves Overdose Victims Soaring Out of ReachFebruary 16th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: